Neomycin And Polymyxin B Sulfate NSN 6505-01-168-6323

NSN: 6505-01-168-6323

Provided with every order

Counterfeit Parts Prevention
100% Product Inspections
7 Year Record Retention
On Time Delivery
HAZMAT Certified
Worldwide Shipping

Get a Quote

Get an up to date price on nsn 6505011686323

Features and Characteristics

Primary Container Type

Tube, collapsible

Primary Container Content Quantity

1.000 ounces

Part Name Assigned By Controlling Agency

Bacitracin, neomycin sulfate, and polymyxin b sulfate ointment

FSC

6505 Drugs And Biologicals

NIIN

011686323

NSN

6505011686323

Manufacturer Part Numbers

Part numbers registered to this national stock number.

Part Number

Cage

Status

MSDS

Part Number:

NDC00168-0012-31

Cage Code:

23301

Status:

MSDS:

Foreign Trade & Schedule B

What is a Schedule B number? Find more information at help.cbp.gov

Schedule B Number: 3004909110
NAICS: 325412
SITC: 54293
Description: Anti-infective medicaments put up in measured doses or forms or packings for retail sale, not elsewhere specified or included
End Use (Code 40100):
Pharmaceutical preparations

Q & A

Frequently asked questions for NSN 6505-01-168-6323

What are the manufacturers of nsn 6505011686323?

Fougera Pharmaceuticals Inc. (23301)
Fougera Pharmaceuticals Inc. (60910)

Does this nsn 6505011686323 have a shelf life?
Yes. 36 mo. after cure date.

What is the formal definition of nsn 6505011686323

Does nsn 6505011686323 contain any precious metals?
Precious metal content is unknown.

Does nsn 6505011686323 contain any hazardous materials?
No information in HMIRS. Hazardous material unknown.

What is the ESD classification of nsn 6505011686323?
No known electrostatic discharge.

Identification Group

Item Identification Guide (IIG) and Item Name Code (INC)

INC

FIIG

App. Key

Cond. Code

Status

INC:

34510

FIIG:

A513W0

App. Key:

Cond. Code:

Status:

What do you get when you order from nationalstocknumber.org?

On Time Delivery
Certificate of Conformance
Quality Inspected Parts
Quality Fast Service